The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
Breakthrough device status for rapid, Point-of-Need molecular diagnostic platform will fill critical gap in early-stage detection of Borrelia bacteria, the cause of Lyme diseaseParis, France, January ...
Franklin Lakes-based BD (Becton, Dickinson and Co.) on Aug. 25 announced the launch of a new, fully automated high-throughput diagnostic system for U.S. labs Using robotics and sample management ...
PLEASANTON, Calif., July 30, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® prime Pre-analytical System to improve efficiency in molecular diagnostics ...
Next-generation sequencing (NGS) platforms, along with immunotherapies like checkpoint inhibitors, have brought the promise of precision medicine for cancer patients closer to reality. Terence Rhodes, ...
Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.
BOSTON & OXFORD, England & CAMBRIDGE, England & TORONTO--(BUSINESS WIRE)--Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement ...
REDWOOD CITY, Calif., Jan. 13, 2026 /PRNewswire/ -- Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building ...
The University of Alabama at Birmingham Departments of Pathology and Genetics jointly offer a one-year ACGME accredited fellowship in molecular genetic pathology. The fellowship is designed to train ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results